CPD Events

ABN symposium

22 May 2024

About the event

This symposium will explore the impact of generalised myasthenia gravis (gMG) on patient Quality of Life (QoL); the need for improved assessment; discuss the early access to medicines scheme (EAMS) real-world efgartigimod data; and explore real-world patient cases. This is a promotional symposium; organised and funded by argenx UK and will contain product-related content and data.

CPD Provider

Argenx UK

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Argenx UK

Argenx UK

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases by translating immunology breakthroughs into potential new medicines. argenx has offices in Belgium, the United States, Japan and Switzerland. 

Want to learn more?